Offer - Urjas Oil for just ₹ 1 X
Arbitel-AM Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Arbitel-AM Tablet have also been mentioned below.
The correct dosage of Arbitel-AM Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Arbitel-AM Tablet are Headache, Dizziness, Palpitations (fluttering in chest). Some other side effects of Arbitel-AM Tablet have been listed ahead. Normally, these side effects of Arbitel-AM Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Arbitel-AM Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Arbitel-AM Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Arbitel-AM Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Coronary Artery Disease (CAD), Angioedema are examples of such conditions.
Drug interactions for Arbitel-AM Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arbitel-AM Tablet is considered not safe while driving, and is not addictive.
Arbitel-AM Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Arbitel-AM Tablet safe for pregnant women?
Arbitel- AM should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Arbitel-AM Tablet safe during breastfeeding?
Taking Arbitel- AM may lead to serious side effects if you are breastfeeding. Arbitel- AM should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Arbitel-AM Tablet on the Kidneys?
Kidney can be affected by Arbitel- AM. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Arbitel-AM Tablet on the Liver?
Arbitel- AM may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Arbitel-AM Tablet on the Heart?
You may experience side effects on your heart after taking Arbitel- AM. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Arbitel-AM Tablet unless your doctor advises you to do so -
Is this Arbitel-AM Tablet habit forming or addictive?
Arbitel-AM Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Arbitel-AM Tablet as you may feel sleepy.
Is it safe?
Arbitel-AM Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Arbitel-AM Tablet is not used to treat mental disorders.
Interaction between Food and Arbitel-AM Tablet
There is no information on the effects of taking Arbitel-AM Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Arbitel-AM Tablet
It is difficult to say anything about the effect of Arbitel-AM Tablet and alcohol. No research has been done on this yet.
Arbitel- AM is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Arbitel- AM might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Arbitel- AM exactly as prescribed by their doctor.
No, Arbitel- AM is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
Yes, Arbitel- AM causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
Arbitel- AM is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Arbitel- AM is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
No, Arbitel- AM does not cause weight gain. Weight gain has rarely been associated with this drug. However, if you are experiencing unusual weight gain and you are in doubt that Arbitel- AM is causing weight gain then discuss with your doctor instantly.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148